Pharmaceutical products in   Canada

Overview In September 2024 Canada's Pharmaceutical products exports accounted up to C$537M and imports accounted up to C$1.86B, resulting in a negative trade balance of C$1.33B. Between September 2023 and September 2024 the exports of Canada's   Pharmaceutical products have decreased by C$-393M (-42.2%) from C$930M to C$537M, while imports increased by C$6.42M (0.35%) from C$1.86B to C$1.86B.

Destinations In September 2024, Pharmaceutical products were exported mostly to United States (C$317M), Japan (C$39.7M), Netherlands (C$15.1M), Australia (C$10.8M), and France (C$10.7M), and were imported mostly from United States (C$624M), Germany (C$184M), Switzerland (C$173M), Ireland (C$170M), and France (C$89.2M).

Growth In September 2024, the decrease in Pharmaceutical products's year-by-year exports was explained primarily by a decrease in exports to Netherlands (C$-390M or -97.6%), Australia (C$-43.1M or -80.5%), and New Zealand (C$-23.7M or -96.3%). In September 2024, the increase in Pharmaceutical products's year-by-year imports was explained primarily by an increase in imports from Switzerland (C$114M or 107%), Germany (C$111M or 76.4%), and Sweden (C$75.3M or 232%).